✨
AI Summary
- Pfizer bullish on oral GLP-1; BMS confidence on Eliquis Medicare pricing.
- Long-term data for Leqembi; NewAmsterdam's CETP inhibitor shows promise.
- Mankind's Bharat Serums buy and other biopharma updates.